rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2003-4-30
|
pubmed:abstractText |
To determine in a prospective study the efficacy, toxicity, and long-term outcome of up-front allogeneic stem-cell transplantation (allo-SCT) in multiple myeloma (MM).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:BargeRenee M YRM,
pubmed-author:CornelissenJan JJJ,
pubmed-author:Dutch-Belgian Hemato-Oncology Cooperative Group,
pubmed-author:LokhorstHenk MHM,
pubmed-author:RaymakersReinierR,
pubmed-author:SchoutenHarry CHC,
pubmed-author:SegerenChristine MCM,
pubmed-author:SonneveldPieterP,
pubmed-author:SteijaertMonique M CMM,
pubmed-author:VerdonckLeo FLF,
pubmed-author:WestveerPetra H MPH,
pubmed-author:van OersMarinus H JMH,
pubmed-author:van der HoltBronnoB
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1728-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12721248-Adult,
pubmed-meshheading:12721248-Female,
pubmed-meshheading:12721248-Humans,
pubmed-meshheading:12721248-Lymphocyte Depletion,
pubmed-meshheading:12721248-Male,
pubmed-meshheading:12721248-Middle Aged,
pubmed-meshheading:12721248-Multiple Myeloma,
pubmed-meshheading:12721248-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:12721248-Prospective Studies,
pubmed-meshheading:12721248-Survival,
pubmed-meshheading:12721248-T-Lymphocytes,
pubmed-meshheading:12721248-Transplantation, Homologous,
pubmed-meshheading:12721248-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM.
|
pubmed:affiliation |
Department of Hematology, University Medical Center Utrecht, HP G03.647, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. H.Lokhorst@azu.nl
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|